Global Wholehealth Partners Corp. (GWHP)

[Animalbar]

SLAP DAT ASK

[Animalbar]

nice info here $GWHP nice ask

[Buy High Sell Now]

Nutritional deficiencies. Not drinking enough liquids (dehydration); not getting enough thiamin (vitamin B-1), which is common in people with chronic alcoholism; and not getting enough vitamins B-6 and B-12 in your diet can cause dementia-like symptoms. Copper and vitamin E deficiencies also can cause dementia symptoms.

[Buy High Sell Now]

The marketing and sales partnership Nunzia Pharmaceutical with 8k filing dated 04/19/2021, gives Global the ability to sell the AstraZeneca Vaccine and the Johnson & Johnson vaccine and other products of Nunzia including their patented nutraceutical for stress and anxiety and soon FDA approved drug for ASD (Autistic Spectrum of Disorders), including Autism, ADD, ADHD, Fragile X, and PTSD. The Nunzia Nutraceutical aids in Nutritional deficiencies and therefore helps people

[Buy High Sell Now]

The products that are planned on being sold in the Philippines are the COVID Antigen, COVID Antibody, Dengue Fever, TB, Malaria, and Influenza A & B.

Coronavirus Cases: 1,184,706 Deaths: 19,983

Dengue Fever cases; 42 584

In 2019, the Philippines had the highest TB incidence in Asia with 554 cases per 100,000 people, according to a World Health Organization (WHO) report. Approximately, 74 Filipinos die of TB every day and are among the top 10 causes of death in the country.

[Buy High Sell Now]

SAN CLEMENTE CA, May 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp (OTC: GWHP) and AAJ has created the best line of products for the Philippines and the surrounding countries. Both companies realize that the ability to carry FDA GMP products assembled in the Philippines will make Global WholeHealth Philippines extremely competitive in the marketplace in the Philippines and other Pacific Rim countries.

[Animalbar]

Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases, with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

[Animalbar]

Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.

[Animalbar]

San Clemente, CA, May 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus.

[Animalbar]

great DD $GWHP

[Buy High Sell Now]

Mr. Charles Strongo, the CEO and Chairman of Global WholeHealth Partners Inc., said: “Global understands the need to be ahead of the virus to conquer the virus. We recognize that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.”

Dr. Vu Le has been a practicing physician for more than 10 years and knows the value of being able to bring testing to the people.

Mr. Strongo continued: “We are happy to have added Dr. Le to our team. He will create, coordinate and implement our push to have children at school and adults at work to get vaccinated as quickly as possible.”

[Buy High Sell Now]

Global WholeHealth Partners Corp. (OTC: GWHP) provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases, with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

[Buy High Sell Now]

The Company offers one of the largest lines of COVID 19 tests, including the strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein.

[Buy High Sell Now]

SAN CLEMENTE, CA, June 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP), a company that offers one of the largest lines of COVID 19 tests including SARS-CoV-2 viruses and that states that its Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses, today announced that they will be bringing their tests directly to the homes and offices of patients in need. To help implement this outreach program, the Company has signed an agreement with Dr. Vu Le to be the Medical Director for the Company’s CLIA WAIVED Mobile Laboratory.

[Animalbar]

$$$$ will be a promising profit $GWHP

[Animalbar]

great finds

[Buy High Sell Now]

some great DD here $GWHP looking nice

[Buy High Sell Now]

yoyo! anita

[Animalbar]

some great DD here $GWHP

[Animalbar]

yoyo Mr W how are ya

[resx18]

Good Morning $GWHP

[Anita Dump]

Good Night GWHP

[Brocool]

Global continues to do research on all new strains of the COVID-19 virus to make sure the tests they offer are useful and reliable diagnostics $GWHP

[Brocool]

GWHP's primary focus is directed towards the global fight against fatal infectious diseases $GWHP

[Brocool]

GWHP's goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market. $GWHP

[Anita Dump]

Welcome Brocool good to meet you $GWHP

[resx18]

Should be a good week here

[Brocool]

GWHP has signed an agreement with Dr. Vu Le to be the Medical Director for the Company’s CLIA WAIVED Mobile Laboratory.$GWHP

[Brocool]

$GWHP waiting on news here!

[Brocool]

Global WholeHealth Partners now has the means to identify and test for Alzheimer's disease using a Micro-Well Reader or Lateral Flow Test to measure the certain brain enzymes during the data collection process used in a positive diagnosis.$GWHP

[Brocool]

Global WholeHealth Partners Corp. is offering one of the largest lines of tests for CoViD19 SARS2. With the vaccine rollout in progress, continued testing for COVID-19 is imperative and needs to remain a top priority to stop the spread of this deadly virus $GWHP

[Anita Dump]

Good Evening GWHP

[Brocool]

GWHP also has international testing, which is not sold in the USA, with an FDA Certificate of Exportability for tests like ZIKA, Rapid Ebola, Rapid Dengue Fever Antibody, and Antigen, Rapid Tuberculosis Rapid Malaria, and many other rapid tests.$GWHP

[Brocool]

Global WholeHealth Partners Corp (GWHP: OTC) is bringing the testing to you, to your school or to your work. 8k filed on 05/14/2021.
Global will be using this CLIA WAIVED Lab to test for COVID 19 Antigen, Antibody, and the other 15 tests that are CLIA WAIVED that Global carries.$GWHP

[Brocool]

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, The Company offers 56 products FDA approved and many are Approved for OTC use. $GWHP

[Brocool]

Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases, with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.$GWHP

[Animalbar]

its a beautiful sight $GWHP $$$

[resx18]

Back to .40 y'all! $GWHP

[Animalbar]

loving this DD $GWHP all the way

[Buy High Sell Now]

“This is the first of many Purchase Orders to Global as Nunzia plans on expansion,” stated Michael Mitsunaga, President of Nunzia Pharmaceutical Inc.

[Buy High Sell Now]

San Clemente, CA, May 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains breakthrough on rising neurological disease and receives its first purchase order from Nunzia Pharmaceutical after the agreement was signed last month.

[Buy High Sell Now]

The marketing and sales partnership with Nunzia Pharmaceutical with 8k filing dated 04/19/2021, gives Global the ability to sell the AstraZeneca Vaccine and the Johnson & Johnson vaccine and other products of Nunzia including their patented nutraceutical for stress and anxiety and soon FDA approved drug for ASD (Autistic Spectrum of Disorders), including Autism, ADD, ADHD, Fragile X, and PTSD. The Nunzia Nutraceutical aids in Nutritional deficiencies and therefore helps people.

[Buy High Sell Now]

“We believe this announcement couldn’t come at a better time for us as we are partnering with Nunzia Pharmaceutical and their products for Neurological disorders,” said Mr. Strongo. “Nunzia Pharmaceutical with nutraceutical for anxiety and stress based on their patented formulas and their pharmaceutical drug they are planning on bringing through the FDA, which specifically works on the Hippocampus part of the brain, dealing with stress, memory, and fine motor skills are a perfect fit for Global’s diagnostic tests,” says Mr. Strongo. “With the new tests for Alzheimer’s, Parkinson’s and Dementia, Global is right in the path of success.”

[Animalbar]

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, The Company offers 56 products FDA approved and many are Approved for OTC use, and 15 POC products approved by the CLIA WAIVED FDA.

[Animalbar]

Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.

[Animalbar]

SAN CLEMENTE CA, May 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp (OTC: GWHP) and AAJ has created the best line of products for the Philippines and the surrounding countries. Both companies realize that the ability to carry FDA GMP products assembled in the Philippines will make Global WholeHealth Philippines extremely competitive in the marketplace in the Philippines and other Pacific Rim countries.

[Animalbar]

yessir! $GWHP

[Animalbar]

great DD here $GWHP looking ready for boom imo

[Buy High Sell Now]

SAN CLEMENTE, CA, June 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP), a company that offers one of the largest lines of COVID 19 tests including SARS-CoV-2 viruses and that states that its Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses, today announced that they will be bringing their tests directly to the homes and offices of patients in need. To help implement this outreach program, the Company has signed an agreement with Dr. Vu Le to be the Medical Director for the Company’s CLIA WAIVED Mobile Laboratory.

[Buy High Sell Now]

Mr. Strongo continued: “We are happy to have added Dr. Le to our team. He will create, coordinate and implement our push to have children at school and adults at work to get vaccinated as quickly as possible.”